Grunze Heinz, Kasper Siegfried, Goodwin Guy, Bowden Charles, Baldwin David, Licht Rasmus W, Vieta Eduard, Möller Hans-Jürgen
Department of Psychiatry, Ludwig-Maximilians-University, Nussbaumstrasse 7, 80336 Munich, Germany.
World J Biol Psychiatry. 2003 Jan;4(1):5-13. doi: 10.3109/15622970309167904.
Identical to the preceding guidelines of this series, these practice guidelines for the biological, mainly pharmacological treatment of acute bipolar mania were developed by an international Task Force of the World Federation of Societies of Biological Psychiatry (WFSBP). Their purpose is to supply a systematic overview of all scientific evidence pertaining to the treatment of acute mania. The data used for these guidelines have been extracted from a MEDLINE and EMBASE search, from recent proceedings of key conferences, and from various national and international treatment guidelines. Their scientific rigor was categorised into four levels of evidence (A-D). As these guidelines are intended for clinical use, the scientific evidence was finally not only graded, but has also been commented by the experts of the task force to ensure practicability. Key words: bipolar disorder, mania, acute treatment, evidence-based guidelines, pharmacotherapy, antipsychotics, mood stabiliser, electroconvulsive therapy.
与本系列之前的指南相同，这些关于急性双相躁狂症生物学（主要是药物）治疗的实践指南由世界生物精神病学协会联合会（WFSBP）的一个国际特别工作组制定。其目的是提供有关急性躁狂症治疗的所有科学证据的系统概述。用于这些指南的数据已从MEDLINE和EMBASE检索、关键会议的近期会议记录以及各种国家和国际治疗指南中提取。其科学严谨性分为四个证据级别（A - D）。由于这些指南旨在用于临床，最终不仅对科学证据进行了分级，而且特别工作组的专家也对其进行了评论以确保实用性。关键词：双相情感障碍、躁狂症、急性治疗、循证指南、药物治疗、抗精神病药物、心境稳定剂、电抽搐治疗。
